ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Phase I Study of MK-4166, an Anti-human Glucocorticoid-Induced TNF Receptor Antibody, Alone or with Pembrolizumab in Advanced Solid Tumors.

Kyriakos P Papadopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.